Methylenebis(thioglycolicaciddi-n-butylesteR)

Catalog No. :
ACRZUM546
CAS No. :
14338-82-0
Molecular Formula :
C13H24O4S2
Molecular Weight :
308.46

IUPAC Name:dibutyl 2,2'-(methylenebis(sulfanediyl))diacetate

Methylenebis(thioglycolicaciddi-n-butylesteR) structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25g95%$88.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethylenebis(thioglycolicaciddi-n-butylesteR)
IUPAC Namedibutyl 2,2'-(methylenebis(sulfanediyl))diacetate
MDL No.MFCD00027216
Molecular FormulaC13H24O4S2
Molecular Weight308.46
SMILESO=C(OCCCC)CSCSCC(OCCCC)=O
InChI KeyQCWRDNFBMVSDEY-UHFFFAOYSA-N
Synonym2,2’-[methylenebis(thio)]bis-aceticacidibutylester;dibutylmethylenedithiodi(acetate);ACETIC ACID 2,2'-[METHYLENEBIS (THIO)] BIS, DIBUTYLESTER;Dibutylmethylendithiodi(acetat);Methylenebis-(mercaptoacetic acid butyl ester);Methylenebis(thioglycolic Acid Dibutyl Ester);Methylenebis(thio)bis(acetic acid butyl) ester;METHYLENE BIS(BUTYL THIOGLYCOLATE)
CAS No.14338-82-0

Safety Data

Pictogram
Harmful or irritantHealth hazardEnvironmental hazard
Signal Word
Gefahr
Hazard Statement(s)
H302-H361-H372-H410
Precautionary Statement(s)
P201-P264-P280-P301+P330+P331-P312

Synthetic Route by SureRoute

1. ACRZUM546 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACWRBI758 route compound structure diagram
    ACWRBI75818991-98-5 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACRZUM546 route product structure diagram
    ACRZUM54614338-82-0
Inquiry

2. ACRZUM546 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACRZUM546 route product structure diagram
    ACRZUM54614338-82-0
Inquiry

Comments (0)